-+ 0.00%
-+ 0.00%
-+ 0.00%

BriaCell Therapeutics Exceeds Enrollment Targets in Pivotal Phase 3 Metastatic Breast Cancer Trial

Reuters·12/09/2025 12:31:04

Please log in to view news